| A novel cationic niosome formulation for gene delivery to the retina G Puras, M Mashal, J Zárate, M Agirre, E Ojeda, S Grijalvo, R Eritja, ... Journal of Controlled Release 174, 27-36, 2014 | 175 | 2014 |
| Cationic niosomes as non-viral vehicles for nucleic acids: Challenges and opportunities in gene delivery S Grijalvo, G Puras, J Zárate, M Sainz-Ramos, NAL Qtaish, T López, ... Pharmaceutics 11 (2), 50, 2019 | 75 | 2019 |
| Retinal gene delivery enhancement by lycopene incorporation into cationic niosomes based on DOTMA and polysorbate 60 M Mashal, N Attia, G Puras, G Martínez-Navarrete, E Fernández, ... Journal of controlled release 254, 55-64, 2017 | 71 | 2017 |
| Stem cell-based gene delivery mediated by cationic niosomes for bone regeneration N Attia, M Mashal, S Grijalvo, R Eritja, J Zárate, G Puras, JL Pedraz Nanomedicine: Nanotechnology, Biology and Medicine 14 (2), 521-531, 2018 | 51 | 2018 |
| Protamine/DNA/niosome ternary nonviral vectors for gene delivery to the retina: the role of protamine G Puras, G Martínez-Navarrete, M Mashal, J Zarate, M Agirre, E Ojeda, ... Molecular pharmaceutics 12 (10), 3658-3671, 2015 | 49 | 2015 |
| Gene delivery to the rat retina by non-viral vectors based on chloroquine-containing cationic niosomes M Mashal, N Attia, G Martinez-Navarrete, C Soto-Sanchez, E Fernandez, ... Journal of Controlled Release 304, 181-190, 2019 | 42 | 2019 |
| Non-viral vectors based on cationic niosomes as efficient gene delivery vehicles to central nervous system cells into the brain M Mashal, N Attia, C Soto-Sánchez, G Martínez-Navarrete, E Fernández, ... International journal of pharmaceutics 552 (1-2), 48-55, 2018 | 41 | 2018 |
| Mesenchymal stem cells: the past present and future N Attia, M Mashal Cell Biology and Translational Medicine, Volume 11: Stem Cell Therapy …, 2020 | 26 | 2020 |
| Elaboration and physicochemical characterization of niosome-based nioplexes for gene delivery purposes E Ojeda, M Agirre, I Villate-Beitia, M Mashal, G Puras, J Zarate, JL Pedraz Non-Viral Gene Delivery Vectors: Methods and Protocols, 63-75, 2016 | 24 | 2016 |
| Mesenchymal stem cells as a gene delivery tool: Promise, problems, and prospects N Attia, M Mashal, G Puras, JL Pedraz Pharmaceutics 13 (6), 843, 2021 | 19 | 2021 |
| Gene transfer to rat cerebral cortex mediated by polysorbate 80 and poloxamer 188 nonionic surfactant vesicles N Attia, M Mashal, C Soto-Sanchez, G Martinez-Navarrete, E Fernandez, ... Drug design, development and therapy, 3937-3949, 2018 | 17 | 2018 |
| Cationic niosome-based hBMP7 gene transfection of neuronal precursor NT2 cells to reduce the migration of glioma cells in vitro N Attia, M Mashal, S Grijalvo, R Eritja, G Puras, JL Pedraz Journal of Drug Delivery Science and Technology 53, 101219, 2019 | 15 | 2019 |
| Cell-based therapy for the treatment of glioblastoma: an update from preclinical to clinical studies N Attia, M Mashal, S Pemminati, A Omole, C Edmondson, W Jones, ... Cells 11 (1), 116, 2021 | 12 | 2021 |
| The use of cerium oxide nanoparticles in liver disorders: A double‐sided coin? N Attia, DM Rostom, M Mashal Basic & Clinical Pharmacology & Toxicology 130 (3), 349-363, 2022 | 7 | 2022 |
| Insights into the potential role of alpha1‐antitrypsin in COVID‐19 patients: Mechanisms, current update, and future perspectives S Marzouk, N Attia, M Mashal The Clinical Respiratory Journal 15 (9), 1019-1024, 2021 | 6 | 2021 |
| Mesenchymal stem cells versus their extracellular vesicles in treatment of liver fibrosis: Is it possible to compare? N Attia, YH Khalifa, DM Rostom, M Mashal Medical Research Archives 9 (2), 2021 | 5 | 2021 |
| Stem cell-derived extracellular vesicles as a potential therapeutic tool for eye diseases: from benchtop to bedside N Attia, YH Khalifa, M Mashal, G Puras, JL Pedraz Cell Biology and Translational Medicine, Volume 19: Perspectives in Diverse …, 2022 | 3 | 2022 |
| Stability of polymeric cationic niosomes and their plasmid DNA-based complexes as gene delivery carriers M Mashal, N Attia, S Grijalvo, R Eritja, G Puras, JL Pedraz Drug delivery 30 (1), 2219420, 2023 | 2 | 2023 |
| Comparative analysis of lipid-peptide nanoparticles prepared via microfluidics, reverse phase evaporation, and ouzo techniques for efficient plasmid DNA delivery M Mashal, N Attia, I Maldonado, LE Rodríguez, I Gallego, G Puras, ... European Journal of Pharmaceutics and Biopharmaceutics, 114385, 2024 | | 2024 |
| Expanding the horizon of transient CAR T therapeutics using virus-free technology L Enriquez-Rodriguez, N Attia, I Gallego, M Mashal, I Maldonado, G Puras, ... Biotechnology Advances, 108350, 2024 | | 2024 |
Jose Luis PedrazProfessor of Pharmaceutical Technology. Universidad Pais Vasco (UPV/EHU)在 ehu.eus 的电子邮件经过验证
